您的位置: 首页 > 农业专利 > 详情页

method to reduce level, treat a condition, treat an inflammatory condition, treat cd16 + disorder, treat an inadequate methotrexate respondent, treat an inadequate tnf inhibitor respondent, identify a subject, predict responsiveness, and methods for treating an inflammatory condition
专利权人:
FIVE PRIME THERAPEUTICS; INC.
发明人:
BRIAN WONG,EMMA MASTELLER,JAMES ALLEN ZANGHI,JULIE HAMBLETON,KEVIN BAKER,KRIS REEDQUIST
申请号:
BR112015004426
公开号:
BR112015004426A2
申请日:
2013.08.30
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
Methods of reducing cytokine levels and methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided. Such methods include, but are not limited to, methods of treating inflammatory conditions, such as rheumatoid arthritis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充